Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NeoGenomics Inc. Common Stock (NEO) vs Stellantis N.V. Common Shares (STLA) Price & Performance

NeoGenomics Inc. Common StockTrade
Stellantis N.V. Common SharesTrade

Price performance (Past 24H)

Key statistics

NeoGenomics Inc. Common Stock vs Stellantis N.V. Common Shares — how do they compare? NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.17B), while Stellantis N.V. Common Shares trades at $4.27 (market cap $16.20B). The key difference: Stellantis N.V. Common Shares is far larger — about 7.5× NeoGenomics Inc. Common Stock's market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, Stellantis N.V. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Stellantis N.V. Common Shares for 0 Days on average.

NEOSTLA
Market Cap
$2.17B$16.20B
Volume
1,615,94330,607,418
Sector
HealthConsumer Cyclical
52-Week High
$19.91$12.12
52-Week Low
$7.19$4.27
Typical Hold Time
0 Days0 Days
Enterprise Value
$2.47B$35.94B

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NEO
100% Buy0% Sell
Avg holding period · 0 Days
STLA
100% Buy0% Sell
Avg holding period · 0 Days

About NeoGenomics Inc. Common Stock

NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.

Read more on NEO →

About Stellantis N.V. Common Shares

Stellantis N.V. is a multinational automaker formed from the 2021 merger of Fiat Chrysler Automobiles and PSA Group, manufacturing vehicles under brands including Jeep, Ram, Chrysler, Dodge, Fiat, Peugeot, and Citroën.

Read more on STLA →